Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance

Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 17.36% to $1.42 following the U.S. Patent and Trademark Office's notice of allowance for a patent titled 'Compositions for the Treatment of Skin Conditions.' Despite this short-term rebound, the stock remains 87.71% lower over the past year and is trading 35.4% below its 100-day simple moving average. Key resistance for the stock is identified at $2.00, with support at $1.00.